Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
1996-8-23
|
pubmed:abstractText |
In order to clarify the association between bcl-2 protein (Bcl-2) expression and genetic alteration, we investigated p53 and DCC (deleted in the colon carcinoma gene locus) gene abnormalities in Bcl-2-positive and -negative gastric carcinomas using a polymerase chain reaction/loss of heterozygosity (LOH) assay. Bcl-2 immunoreactivity was found in 25 of 178 (14%) gastric carcinoma cases. With these 25 positive cases, the proportion 18/87 (20.6%) of the total in early stages demonstrating invasion of the mucosa and/or submucosa was significantly greater (P = 0.013) than the 7/91 (7.7%) found for advanced tumors exhibiting invasion into or through the muscularis propria. However, there was no statistically significant variation between the proportions for differentiated (17/98 cases, 17.3%) and undifferentiated (8/80 cases, 10%) lesions. Sixteen Bcl-2-positive cases (9 cases were not studied because of insufficient specimen material to allow extraction of DNA) and 31 cases randomly selected from a Bcl-2-negative group were analyzed for the presence of p53-LOH or DCC-LOH and for p53 by immuno-histochemistry. The minority of the Bcl-2-positive group had p53-LOH and were immunopositive for p53 (P = 0.033, P = 0.028 respectively), while no association was found in the Bcl-2-negative category. In contrast, there was no correlation at all between Bcl-2 expression and DCC-LOH although the number of informative cases analyzed was too small to allow definite conclusions. These results indicate that Bcl-2 may be predominantly expressed at an early stage in gastric carcinomas, possibly in negative association with p53 gene abnormalities.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0171-5216
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
122
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
427-32
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8690754-Alleles,
pubmed-meshheading:8690754-Base Sequence,
pubmed-meshheading:8690754-Cell Nucleus,
pubmed-meshheading:8690754-Cytoplasm,
pubmed-meshheading:8690754-Gene Deletion,
pubmed-meshheading:8690754-Gene Expression,
pubmed-meshheading:8690754-Genes, DCC,
pubmed-meshheading:8690754-Genes, p53,
pubmed-meshheading:8690754-Heterozygote,
pubmed-meshheading:8690754-Humans,
pubmed-meshheading:8690754-Immunohistochemistry,
pubmed-meshheading:8690754-Molecular Sequence Data,
pubmed-meshheading:8690754-Polymerase Chain Reaction,
pubmed-meshheading:8690754-Proto-Oncogene Proteins,
pubmed-meshheading:8690754-Proto-Oncogene Proteins c-bcl-2,
pubmed-meshheading:8690754-Stomach Neoplasms
|
pubmed:year |
1996
|
pubmed:articleTitle |
Bcl-2 expression and allelic loss of the p53 gene in gastric carcinomas.
|
pubmed:affiliation |
Department of Pathology, Kitasato University, School of Medicine, Kanagawa, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|